HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 667,288 shares of the company’s stock after selling 18,703 shares during the period. Wellington Management Group LLP owned approximately 0.78% of HealthEquity worth $44,241,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in HQY. Janney Montgomery Scott LLC purchased a new stake in HealthEquity during the 3rd quarter worth approximately $217,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of HealthEquity during the third quarter valued at $41,000. Envestnet Portfolio Solutions Inc. purchased a new stake in shares of HealthEquity during the third quarter valued at $269,000. Envestnet Asset Management Inc. increased its position in shares of HealthEquity by 41.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 84,617 shares of the company’s stock valued at $6,181,000 after acquiring an additional 24,685 shares during the period. Finally, Invesco Ltd. raised its stake in HealthEquity by 164.6% in the 3rd quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock worth $35,359,000 after acquiring an additional 301,078 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on HQY shares. BTIG Research increased their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. JMP Securities raised their price target on shares of HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. Robert W. Baird upped their price objective on shares of HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. Bank of America increased their price objective on shares of HealthEquity from $97.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, June 4th. Finally, Barrington Research boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $101.67.

Insider Activity at HealthEquity

In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the sale, the director now directly owns 32,123 shares in the company, valued at $2,547,032.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other HealthEquity news, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Vice Chairman Stephen Neeleman sold 400 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $85.00, for a total transaction of $34,000.00. Following the sale, the insider now directly owns 90,515 shares of the company’s stock, valued at approximately $7,693,775. The disclosure for this sale can be found here. Insiders sold a total of 34,980 shares of company stock worth $2,787,746 in the last 90 days. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Trading Up 1.7 %

Shares of HealthEquity stock opened at $83.64 on Monday. The firm has a 50-day simple moving average of $80.67 and a two-hundred day simple moving average of $77.64. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. HealthEquity, Inc. has a fifty-two week low of $59.02 and a fifty-two week high of $87.72. The company has a market cap of $7.28 billion, a P/E ratio of 90.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.55.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.